Business Context and Reporting Period
This Form 8-K is a current report filed by Shuttle Pharmaceuticals Holdings, Inc. (SHPH) on March 5, 2024, covering events occurring on February 29, 2024, and March 5, 2024. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Gaithersburg, MD. Its common stock trades on The Nasdaq Stock Market LLC under the symbol "SHPH."
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
The primary material event reported is the resolution of a Nasdaq listing deficiency regarding the minimum bid price requirement.
- Deficiency: The Company previously received notice that its stock closed below $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
- Initial Grace Period: The initial 180-day grace period to regain compliance ended on February 27, 2024, without the Company meeting the requirement.
- Compliance Plan: On February 19, 2024, the Company submitted a plan to Nasdaq seeking an extension, which included the potential implementation of a reverse stock split.
- Approval: On February 29, 2024, Nasdaq granted an additional 180-day grace period, extending the deadline to regain compliance to August 26, 2024.
Guidance, Outlook, and Risks
Outlook and Management Commentary: Management intends to monitor the closing bid price and will consider available options, including a reverse split, to regain compliance before the August 26, 2024 deadline. Additionally, CEO Dr. Anatoly Dritschilo is scheduled to participate in the Emerging Growth Conference on March 6, 2024.
Risks and Contingencies:
- Delisting Risk: If the Company fails to maintain a closing bid price of at least $1.00 for 10 consecutive business days by August 26, 2024, its stock will be subject to delisting.
- Appeal Process: In the event of a delisting determination, the Company may appeal to a Nasdaq Hearings Panel, though there is no assurance of success.
- Uncertainty: The filing explicitly states there can be no assurance that the Company will regain compliance or maintain other listing requirements.
Investor Verification Checklist
- Verify the current trading price of SHPH to assess proximity to the $1.00 compliance threshold.
- Monitor for future announcements regarding the execution of a reverse stock split.
- Review the press release dated March 5, 2024 (Exhibit 99.1) for details on the CEO's conference participation.
- Track the August 26, 2024 deadline for the final determination of Nasdaq listing status.